Skip to main content
. 2020 Aug 11;8:758. doi: 10.3389/fcell.2020.00758

FIGURE 2.

FIGURE 2

Recent molecular findings by “-omic technology” in the ovarian cancer tumor microenvironment (TME). With the tools of genomic, transcriptomic, proteomic technology, a comprehensive multi-level landscape of ovarian cancer TME is revealed. With data are drawn from the “-omic scope,” the molecular profile of ovarian cancer is further identified in terms of tumor heterogeneity and treatment impact; new discoveries on factors that are either positively or negatively associated with tumor progression are also identified, providing clues for treatment target exploration and novel biomarker designing for disease screening, staging, diagnosis, and prognosis; also, correlations between certain therapeutic regimens and ovarian cancer TME profiles are investigated, providing implication for precision medicine by precise patient selection.